176 related articles for article (PubMed ID: 27863432)
1. E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing.
Millán-Uclés Á; Zuluaga S; Marqués M; Vallejo-Díaz J; Sanz L; Cariaga-Martínez AE; Real FX; Carrera AC
Oncotarget; 2016 Dec; 7(51):84054-84071. PubMed ID: 27863432
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of
Yao LZ; Zhu YL; Liu JJ
Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting PI3Kβ with AZD8186 Regulates Key Metabolic Pathways in PTEN-Null Tumors.
Lynch JT; Polanska UM; Delpuech O; Hancox U; Trinidad AG; Michopoulos F; Lenaghan C; McEwen R; Bradford J; Polanski R; Ellston R; Avivar-Valderas A; Pilling J; Staniszewska A; Cumberbatch M; Critchlow SE; Cruzalegui F; Barry ST
Clin Cancer Res; 2017 Dec; 23(24):7584-7595. PubMed ID: 28972046
[No Abstract] [Full Text] [Related]
4. Frequent PTEN loss and differential HER2/PI3K signaling pathway alterations in salivary duct carcinoma: Implications for targeted therapy.
Saintigny P; Mitani Y; Pytynia KB; Ferrarotto R; Roberts DB; Weber RS; Kies MS; Maity SN; Lin SH; El-Naggar AK
Cancer; 2018 Sep; 124(18):3693-3705. PubMed ID: 30289966
[TBL] [Abstract][Full Text] [Related]
5. Concomitant Inhibition of PI3Kβ and BRAF or MEK in PTEN-Deficient/BRAF-Mutant Melanoma Treatment: Preclinical Assessment of SAR260301 Oral PI3Kβ-Selective Inhibitor.
Bonnevaux H; Lemaitre O; Vincent L; Levit MN; Windenberger F; Halley F; Delorme C; Lengauer C; Garcia-Echeverria C; Virone-Oddos A
Mol Cancer Ther; 2016 Jul; 15(7):1460-71. PubMed ID: 27196754
[TBL] [Abstract][Full Text] [Related]
6. BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells.
Tsui KH; Chiang KC; Lin YH; Chang KS; Feng TH; Juang HH
Cancer Med; 2018 Jan; 7(1):184-195. PubMed ID: 29239139
[TBL] [Abstract][Full Text] [Related]
7. PTEN-deficient cancers depend on PIK3CB.
Wee S; Wiederschain D; Maira SM; Loo A; Miller C; deBeaumont R; Stegmeier F; Yao YM; Lengauer C
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):13057-62. PubMed ID: 18755892
[TBL] [Abstract][Full Text] [Related]
8. PTEN restoration and PIK3CB knockdown synergistically suppress glioblastoma growth in vitro and in xenografts.
Chen H; Mei L; Zhou L; Shen X; Guo C; Zheng Y; Zhu H; Zhu Y; Huang L
J Neurooncol; 2011 Aug; 104(1):155-67. PubMed ID: 21188471
[TBL] [Abstract][Full Text] [Related]
9. A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
Wang L; Šuštić T; Leite de Oliveira R; Lieftink C; Halonen P; van de Ven M; Beijersbergen RL; van den Heuvel MM; Bernards R; van der Heijden MS
Eur Urol; 2017 Jun; 71(6):858-862. PubMed ID: 28108151
[TBL] [Abstract][Full Text] [Related]
10. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
11. Discovery and optimization of new benzimidazole- and benzoxazole-pyrimidone selective PI3Kβ inhibitors for the treatment of phosphatase and TENsin homologue (PTEN)-deficient cancers.
Certal V; Halley F; Virone-Oddos A; Delorme C; Karlsson A; Rak A; Thompson F; Filoche-Rommé B; El-Ahmad Y; Carry JC; Abecassis PY; Lejeune P; Vincent L; Bonnevaux H; Nicolas JP; Bertrand T; Marquette JP; Michot N; Benard T; Below P; Vade I; Chatreaux F; Lebourg G; Pilorge F; Angouillant-Boniface O; Louboutin A; Lengauer C; Schio L
J Med Chem; 2012 May; 55(10):4788-805. PubMed ID: 22524426
[TBL] [Abstract][Full Text] [Related]
12. Loss of DeltaNp63alpha promotes invasion of urothelial carcinomas via N-cadherin/Src homology and collagen/extracellular signal-regulated kinase pathway.
Fukushima H; Koga F; Kawakami S; Fujii Y; Yoshida S; Ratovitski E; Trink B; Kihara K
Cancer Res; 2009 Dec; 69(24):9263-70. PubMed ID: 19934319
[TBL] [Abstract][Full Text] [Related]
13. Ectodomain-specific E-cadherin antibody suppresses skin SCC growth and reduces tumor grade: a multitargeted therapy modulating RTKs and the PTEN-p53-MDM2 axis.
Brouxhon SM; Kyrkanides S; Raja V; Silberfeld A; Teng X; Trochesset D; Cohen J; Ma L
Mol Cancer Ther; 2014 Jul; 13(7):1791-802. PubMed ID: 24748654
[TBL] [Abstract][Full Text] [Related]
14. PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular Carcinoma.
Boelens MC; Nethe M; Klarenbeek S; de Ruiter JR; Schut E; Bonzanni N; Zeeman AL; Wientjens E; van der Burg E; Wessels L; van Amerongen R; Jonkers J
Cell Rep; 2016 Aug; 16(8):2087-2101. PubMed ID: 27524621
[TBL] [Abstract][Full Text] [Related]
15. The PTEN/Akt Signaling Pathway Mediates Myocardial Apoptosis in Swine After Coronary Microembolization.
Wang J; Chen H; Su Q; Zhou Y; Liu T; Li L
J Cardiovasc Pharmacol Ther; 2016 Sep; 21(5):471-7. PubMed ID: 26846271
[TBL] [Abstract][Full Text] [Related]
16. Integrin-linked kinase regulates cadherin switch in bladder cancer.
Gil D; Ciołczyk-Wierzbicka D; Dulińska-Litewka J; Laidler P
Tumour Biol; 2016 Nov; 37(11):15185-15191. PubMed ID: 27683053
[TBL] [Abstract][Full Text] [Related]
17. Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness.
Kim CJ; Terado T; Tambe Y; Mukaisho KI; Sugihara H; Kawauchi A; Inoue H
Int J Oncol; 2018 Jan; 52(1):231-240. PubMed ID: 29115414
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis.
Luo HB; Li B; Yuan WG; Xu CR
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):730-735. PubMed ID: 26489630
[TBL] [Abstract][Full Text] [Related]
19. microRNA-495 promotes bladder cancer cell growth and invasion by targeting phosphatase and tensin homolog.
Tan M; Mu X; Liu Z; Tao L; Wang J; Ge J; Qiu J
Biochem Biophys Res Commun; 2017 Feb; 483(2):867-873. PubMed ID: 28069380
[TBL] [Abstract][Full Text] [Related]
20. Frequent mono-allelic loss associated with deficient PTEN expression in imatinib-resistant gastrointestinal stromal tumors.
Quattrone A; Wozniak A; Dewaele B; Floris G; Vanspauwen V; Van Looy T; Schöffski P; Rutkowski P; Sciot R; Debiec-Rychter M
Mod Pathol; 2014 Nov; 27(11):1510-20. PubMed ID: 24743220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
